trending Market Intelligence /marketintelligence/en/news-insights/trending/dADL0kM0tXNt_uuFhgydaQ2 content esgSubNav
In This List

Immune Pharmaceuticals appoints COO

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Immune Pharmaceuticals appoints COO

Immune Pharmaceuticals Inc. appointed Tony Fiorino to the joint position of chief medical officer and COO of the company.

Fiorino previously served as president and CEO of Triumvira Immunologics, an immuno-oncology company developing an engineered T cell platform.